Allurion Technologies, Inc. (ALUR) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.079x

Based on the latest financial reports, Allurion Technologies, Inc. (ALUR) has a cash flow conversion efficiency ratio of 0.079x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.54 Million) by net assets ($-82.93 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Allurion Technologies, Inc. - Cash Flow Conversion Efficiency Trend (2020–2024)

This chart illustrates how Allurion Technologies, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Allurion Technologies, Inc. total liabilities for a breakdown of total debt and financial obligations.

Allurion Technologies, Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Allurion Technologies, Inc. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Brunner Investment Trust
LSE:BUT
0.004x
T.Krungthai Industries Public Company Limited
BK:TKT
0.037x
Fidelity Emerging Markets Ord
LSE:FEML
0.103x
HLT Global Bhd
KLSE:0188
-0.159x
Emerson Radio Corporation
NYSE MKT:MSN
-0.106x
Aeris Environmental Ltd
AU:AEI
0.033x
WH Smith PLC
LSE:SMWH
0.974x
Profusa, Inc. Common Stock
NASDAQ:PFSA
0.313x

Annual Cash Flow Conversion Efficiency for Allurion Technologies, Inc. (2020–2024)

The table below shows the annual cash flow conversion efficiency of Allurion Technologies, Inc. from 2020 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Allurion Technologies, Inc..

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $-77.98 Million $-42.30 Million 0.542x -40.24%
2023-12-31 $-70.49 Million $-63.98 Million 0.908x -37.57%
2022-12-31 $-32.31 Million $-46.98 Million 1.454x +247.87%
2021-12-31 $-34.28 Million $-14.33 Million 0.418x +23780.36%
2020-12-31 $19.83K $-35.00 -0.002x --

About Allurion Technologies, Inc.

NYSE:ALUR USA Medical Devices
Market Cap
$7.86 Million
Market Cap Rank
#27416 Global
#5429 in USA
Share Price
$0.64
Change (1 day)
-6.91%
52-Week Range
$0.26 - $3.26
All Time High
$10.69
About

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehea… Read more